Your browser doesn't support javascript.
loading
Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
Becerra-Tomás, Nerea; Markozannes, Georgios; Cariolou, Margarita; Balducci, Katia; Vieira, Rita; Kiss, Sonia; Aune, Dagfinn; Greenwood, Darren C; Dossus, Laure; Copson, Ellen; Renehan, Andrew G; Bours, Martijn; Demark-Wahnefried, Wendy; Hudson, Melissa M; May, Anne M; Odedina, Folakemi T; Skinner, Roderick; Steindorf, Karen; Tjønneland, Anne; Velikova, Galina; Baskin, Monica L; Chowdhury, Rajiv; Hill, Lynette; Lewis, Sarah J; Seidell, Jaap; Weijenberg, Matty P; Krebs, John; Cross, Amanda J; Tsilidis, Konstantinos K; Chan, Doris S M.
Afiliação
  • Becerra-Tomás N; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Markozannes G; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Cariolou M; Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.
  • Balducci K; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Vieira R; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Kiss S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Aune D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Greenwood DC; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Dossus L; Department of Nutrition, Oslo New University College, Oslo, Norway.
  • Copson E; Department of Research, The Cancer Registry of Norway, Oslo, Norway.
  • Renehan AG; Leeds Institute for Data Analytics, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Bours M; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Demark-Wahnefried W; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Hudson MM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • May AM; Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Odedina FT; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Skinner R; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Steindorf K; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Tjønneland A; Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, USA.
  • Velikova G; Department of Paediatric and Adolescent Haematology/Oncology, Great North Children's Hospital and Translational and Clinical Research Institute, and Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Baskin ML; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Chowdhury R; Danish Cancer Society Research Center, Diet, Cancer and Health, Copenhagen, Denmark.
  • Hill L; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Lewis SJ; School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Seidell J; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Weijenberg MP; Department of Global Health, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.
  • Krebs J; World Cancer Research Fund International, London, UK.
  • Cross AJ; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Tsilidis KK; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Chan DSM; Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Int J Cancer ; 155(3): 400-425, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38692659
ABSTRACT
The adiposity influence on colorectal cancer prognosis remains poorly characterised. We performed a systematic review and meta-analysis on post-diagnosis adiposity measures (body mass index [BMI], waist circumference, waist-to-hip ratio, weight) or their changes and colorectal cancer outcomes. PubMed and Embase were searched through 28 February 2022. Random-effects meta-analyses were conducted when at least three studies had sufficient information. The quality of evidence was interpreted and graded by the Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel. We reviewed 124 observational studies (85 publications). Meta-analyses were possible for BMI and all-cause mortality, colorectal cancer-specific mortality, and cancer recurrence/disease-free survival. Non-linear meta-analysis indicated a reverse J-shaped association between BMI and colorectal cancer outcomes (nadir at BMI 28 kg/m2). The highest risk, relative to the nadir, was observed at both ends of the BMI distribution (18 and 38 kg/m2), namely 60% and 23% higher risk for all-cause mortality; 95% and 26% for colorectal cancer-specific mortality; and 37% and 24% for cancer recurrence/disease-free survival, respectively. The higher risk with low BMI was attenuated in secondary analyses of RCTs (compared to cohort studies), among studies with longer follow-up, and in women suggesting potential methodological limitations and/or altered physiological state. Descriptively synthesised studies on other adiposity-outcome associations of interest were limited in number and methodological quality. All the associations were graded as limited (likelihood of causality no conclusion) due to potential methodological limitations (reverse causation, confounding, selection bias). Additional well-designed observational studies and interventional trials are needed to provide further clarification.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Índice de Massa Corporal / Adiposidade Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Índice de Massa Corporal / Adiposidade Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido